logo

The Future of Viking Therapeutics Inc: Analyzing VKTX

In terms of market performance, Viking Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $99.41 on 02/28/24, and the lowest value was recorded at $8.28 on 10/26/23.

52-week price history of VKTX Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Viking Therapeutics Inc’s current trading price is -36.32% away from its 52-week high, while its distance from the 52-week low is 664.49%. The stock’s price range during the 52-week period has remained between $8.28 and $99.41. In the Healthcare sector, the company’s shares saw a trading volume of around 5.12 million for the day, which was evidently lower than the average daily volume of 5.73 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Viking Therapeutics Inc (VKTX) has experienced a quarterly rise of 250.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.92B and boasts a workforce of 27 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 24.95, with a change in price of +53.34. Similarly, Viking Therapeutics Inc recorded 4,477,036 in trading volume during the last 100 days, posting a change of +495.72%.

Examining VKTX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VKTX Stock Stochastic Average

Viking Therapeutics Inc’s raw stochastic average for the past 50 days is presently 57.03%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 49.26%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 58.55% and 70.10%, respectively.

VKTX Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 240.14%. However, over the last six months, the performance has been weaker by 298.36%. The price of VKTX increased 119.11% over the last 30 days. And in the last five days, it has fallen by -30.70%.